Literature DB >> 21382886

Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men.

A Ratkevicius1, A Joyson, I Selmer, T Dhanani, C Grierson, A M Tommasi, A DeVries, P Rauchhaus, D Crowther, S Alesci, P Yaworsky, F Gilbert, T W Redpath, J Brady, K C H Fearon, D M Reid, C A Greig, H Wackerhage.   

Abstract

Sarcopenia is the loss of muscle size and function during ageing. The aim of this study was to test whether serum concentrations of myostatin and interacting proteins (GASP-1, FLRG, and follistatin) differed between young and elderly sarcopenic men. Isometric knee extensor maximal voluntary contraction and quadriceps cross-sectional area (magnetic resonance imaging measurement) were significantly higher in young (22 ± 2 years; 266 ± 54 N/m; 8,686 ± 1,154 mm(2)) than in mildly sarcopenic (69 ± 3 years; 183 ± 17 N/m; 6,621±718 mm(2)) and severely sarcopenic men (76 ± 6 years; 127 ± 23 N/m; 5,846 ± 591 mm(2)), respectively (p ≤ .01 for all comparisons). There was a trend (p = .06) toward higher FLRG in young (20 ± 8 ng/mL) than in mildly (15 ± 6 ng/mL) and severely sarcopenic men (17 ± 8 ng/mL). Myostatin, follistatin, GASP-1, tumor necrosis factor α, and interleukin-6 did not differ significantly. Insulin-like growth factor-1 and free testosterone were both significantly lower in sarcopenic men (p < .001). This suggests that altered serum concentrations of myostatin and myostatin-interacting proteins are not contributing to sarcopenia with the possible exception of FLRG.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382886     DOI: 10.1093/gerona/glr025

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  36 in total

1.  A targeted proteomic assay for the measurement of plasma proteoforms related to human aging phenotypes.

Authors:  Richard D Semba; Pingbo Zhang; Min Zhu; Elisa Fabbri; Marta Gonzalez-Freire; Ruin Moaddel; Minghui Geng-Spyropoulos; Luigi Ferrucci
Journal:  Proteomics       Date:  2017-08       Impact factor: 3.984

2.  Reduced serum myostatin concentrations associated with genetic muscle disease progression.

Authors:  Peter M Burch; Oksana Pogoryelova; Joe Palandra; Richard Goldstein; Donald Bennett; Lori Fitz; Michela Guglieri; Chiara Marini Bettolo; Volker Straub; Teresinha Evangelista; Hendrik Neubert; Hanns Lochmüller; Carl Morris
Journal:  J Neurol       Date:  2017-01-10       Impact factor: 4.849

Review 3.  Atrogin-1, MuRF-1, and sarcopenia.

Authors:  Jonathan P Gumucio; Christopher L Mendias
Journal:  Endocrine       Date:  2012-07-20       Impact factor: 3.633

Review 4.  Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.

Authors:  Giovanni Lombardi; Veronica Sansoni; Giuseppe Banfi
Journal:  Ann Transl Med       Date:  2017-08

Review 5.  Current understanding of sarcopenia: possible candidates modulating muscle mass.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Pflugers Arch       Date:  2014-05-07       Impact factor: 3.657

Review 6.  Molecular mechanism of sarcopenia and cachexia: recent research advances.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Pflugers Arch       Date:  2017-01-19       Impact factor: 3.657

Review 7.  Myostatin--the holy grail for muscle, bone, and fat?

Authors:  B Buehring; N Binkley
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

Review 8.  Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.

Authors:  J Rodriguez; B Vernus; I Chelh; I Cassar-Malek; J C Gabillard; A Hadj Sassi; I Seiliez; B Picard; A Bonnieu
Journal:  Cell Mol Life Sci       Date:  2014-07-31       Impact factor: 9.261

9.  Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults.

Authors:  J Chew; L Tay; J P Lim; B P Leung; A Yeo; S Yew; Y Y Ding; W S Lim
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

10.  Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults.

Authors:  L Tay; Y Y Ding; B P Leung; N H Ismail; A Yeo; S Yew; K S Tay; C H Tan; M S Chong
Journal:  Age (Dordr)       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.